Abbott Laboratories logo
Abbott Laboratories (ABT)
Compare

Abbott Laboratories (ABT) Earnings Per Share (EPS): 3.59

Is Abbott Laboratories’s earnings per share (EPS) high or low?

Abbott Laboratories's earnings per share (EPS) of 3.59 is 14% below its 5-year average of 4.19, near the low end of its 5-year range (2.52–7.67).

The earnings per share (EPS) for Abbott Laboratories (ABT) is 3.59 as of Wednesday, June 10, 2026. It is below its 12-month average by 37.07% (5.71).

ABT Earnings Per Share (EPS) Chart

ABT Earnings Per Share (EPS)
3.74-51.24% 1Y
Zoom

ABT Average Earnings Per Share (EPS) Chart

ABT Current vs Average Earnings Per Share (EPS) Chart

ABT Earnings Per Share (EPS) Metrics

EARNINGS PER SHARE (EPS)

3.59

EARNINGS PER SHARE (EPS) AVG TTM

5.71

EARNINGS PER SHARE (EPS) AVG 3Y

4.66

EARNINGS PER SHARE (EPS) AVG 5Y

4.19

EARNINGS PER SHARE (EPS) AVG 10Y

2.98

EARNINGS PER SHARE (EPS) AVG 15Y

2.86

EARNINGS PER SHARE (EPS) AVG 20Y

2.77

CURRENT VS TTM AVG

-37.07%

CURRENT VS 3Y AVG

-23.00%

CURRENT VS 5Y AVG

-14.32%

CURRENT VS 10Y AVG

+20.47%

CURRENT VS 15Y AVG

+25.61%

CURRENT VS 20Y AVG

+29.45%

ABT Competitors' Earnings Per Share (EPS)

NAMEMARKET CAPEARNINGS PER SHARE (EPS)TTM3Y5Y
Abbott Laboratories (ABT)$154.66B3.595.714.664.19
Gilead Sciences, Inc. (GILD)$151.21B7.343.613.853.41
Intuitive Surgical, Inc. (ISRG)$146.44B8.257.275.845.20
Pfizer Inc. (PFE)$146.36B1.311.392.192.39
Danaher Corporation (DHR)$130.25B5.175.206.666.73
Thermo Fisher Scientific Inc. (TMO)$179.45B18.1917.1716.9017.22
Amgen Inc. (AMGN)$183.75B14.3710.9711.6711.57
CVS Health Corporation (CVS)$125.16B2.272.533.714.39
Bristol-Myers Squibb Company (BMY)$114.14B3.56-0.481.470.84
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B16.866.6910.109.99

EPS Comparison

Trailing EPS (TTM)

$3.59

Forward EPS (Est.)

$6.05

P/E Ratio

24.7

Formula: EPS = Net Income / Weighted Average Shares Outstanding

Why EPS matters:

  • Directly impacts stock valuation through P/E ratio
  • Used to calculate dividend coverage and payout ratios
  • Enables comparison across companies of different sizes
  • Growth in EPS often correlates with stock price appreciation

Abbott Laboratories Earnings Per Share (EPS) Formula & Definition

EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Abbott Laboratories Earnings Per Share (EPS) FAQ

What is the earnings per share (EPS) for Abbott Laboratories (ABT)?
The earnings per share (EPS) for ABT stock is 3.59.
Is Abbott Laboratories's earnings per share (EPS) high or low?
Abbott Laboratories's earnings per share (EPS) of 3.59 is 14% below its 5-year average of 4.19, near the low end of its 5-year range (2.52–7.67).
What is the TTM average earnings per share (EPS) for Abbott Laboratories (ABT)?
The TTM average earnings per share (EPS) for ABT stock is 5.71.
What is the 3Y average earnings per share (EPS) for Abbott Laboratories (ABT)?
The 3Y average earnings per share (EPS) for ABT stock is 4.66.
What is the 5Y average earnings per share (EPS) for Abbott Laboratories (ABT)?
The 5Y average earnings per share (EPS) for ABT stock is 4.19.
What is the 10Y average earnings per share (EPS) for Abbott Laboratories (ABT)?
The 10Y average earnings per share (EPS) for ABT stock is 2.98.
What is the 15Y average earnings per share (EPS) for Abbott Laboratories (ABT)?
The 15Y average earnings per share (EPS) for ABT stock is 2.86.
What is the 20Y average earnings per share (EPS) for Abbott Laboratories (ABT)?
The 20Y average earnings per share (EPS) for ABT stock is 2.77.

Abbott Laboratories Earnings Per Share (EPS) History

DATEEARNINGS PER SHARE (EPS)
2025-12-313.74
2024-12-317.67
2023-12-313.30
2022-12-313.94
2021-12-313.97
2020-12-312.52
2019-12-312.07
2018-12-311.35
2017-12-310.27
2016-12-310.95
2015-12-313.00
2014-12-311.51
2013-12-311.66
2012-12-313.78
2011-12-313.01
2010-12-312.99
2009-12-313.72
2008-12-313.16
2007-12-312.34
2006-12-311.12
2005-12-312.17
2004-12-312.07
2003-12-311.76
2002-12-311.79
2001-12-311.00
2000-12-311.80
1999-12-311.59
1998-12-311.52
1997-12-311.35
1996-12-311.21

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL
114,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert Ford